ArticleBioinformation2026
Comparative analysis on the effect of vagus nerve stimulation in reducing post-operative inflammation and enhancing recovery outcomes after surgery.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive post-operative inflammation remains a major cause of complications, delayed recovery and prolonged hospitalization after major surgery. Therefore, it is of interest to evaluate the effect of perioperative transcutaneous auricular vagus nerve stimulation (taVNS) on inflammatory biomarkers and recovery outcomes in 90 patients undergoing elective abdominal and cardiothoracic surgery. Patients receiving taVNS demonstrated significantly lower IL-6, TNF-α and CRP levels, together with higher IL-10 concentrations, than those receiving standard care. The taVNS group also showed earlier ambulation, lower pain scores, reduced analgesic requirements and shorter hospital stays. Thus, data shows the taVNS as a safe, non-invasive neuromodulatory strategy that effectively suppresses post-operative inflammation while accelerating clinical recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.